CardioGenesis Laser Therapies for Angina and Heart Disease Patients Q4 02 Results Page 5
CARDIOGENESIS REPORTS 2002 FOURTH QUARTER, YEAR END RESULTS
PAGE 5-5-5
CARDIOGENESIS CORPORATION
CONDENSED AND CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
December 31,
December 31,
2002 2001
ASSETS
Cash and cash equivalents
$ 1,490
$ 2,629
Accounts receivable, net
1,961
2,330
Inventories
1,632
3,215
Property and equipment, net
589
863
Other assets
2,083
2,272
Total assets
$ 7,755
$ 11,309
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable and accrued liabilities
$ 3,423
$ 6,796
Deferred revenue
621
931
Shareholders' equity
3,711
3,582
Total liabilities and shareholders' equity
$ 7,755
$ 11,309
# # # #
